Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Balance Sheets

v3.23.2
Condensed Consolidated Balance Sheets - USD ($)
$ in Thousands
Jun. 30, 2023
Dec. 31, 2022
Current assets:    
Cash and cash equivalents $ 9,743 $ 6,830
Marketable debt securities 12,770 21,933
Restricted cash – security deposit 50 50
Prepaid expenses and other current assets 1,437 5,719
Total current assets 24,000 34,532
Non-current assets:    
Leasehold improvements and equipment – net 2,103 2,091
Operating lease right-of-use assets – net 3,345 3,613
Finance lease right-of-use assets – net 24 30
In-process research and development 3,017 3,017
Goodwill 1,336 1,336
Restricted cash – security deposit 200 200
Total non-current assets 10,025 10,287
Total assets 34,025 44,819
Current liabilities:    
Accounts payable 604 618
Accrued expenses 1,372 3,099
Operating lease liabilities – current 608 562
Financing lease liabilities – current 5 7
Total current liabilities 2,589 4,286
Non-current liabilities:    
Deferred tax liability 341 341
Operating lease liabilities – net of current portion 3,221 3,533
Financing lease liabilities – net of current portion 20 22
Total non-current liabilities 3,582 3,896
Total liabilities 6,171 8,182
Stockholders’ equity:    
Common stock par value $0.0001 per share, 500,000,000 shares authorized at June 30, 2023 and December 31, 2022; 217,264,526 issued and outstanding as of June 30, 2023 and December 31, 2022 22 22
Additional paid-in capital 192,550 190,070
Accumulated deficit (164,204) (152,631)
Accumulated other comprehensive loss (514) (824)
Total stockholders’ equity 27,854 36,637
Total liabilities and stockholders’ equity $ 34,025 $ 44,819